Study Finds Zinc Doesn't Reduce Mortality, Other Health Risks, for Heavy Alcohol Users Living With HIV/AIDS
June 25, 2020
June 25, 2020
NASHVILLE, Tennessee, June 25 -- Vanderbilt University Medical Center issued the following news:
Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study.
Although low adherence likely influenced the outcome in the trial, zinc significantly lowered mortality risk among those who were adherent, said the study's lead au . . .
Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study.
Although low adherence likely influenced the outcome in the trial, zinc significantly lowered mortality risk among those who were adherent, said the study's lead au . . .